Recombinant Human ABCA3 Protein，His

ABCA3 (ATP-binding cassette sub-family A member 3) is a critical protein primarily expressed in the epithelial cells of the lung, playing a vital role in surfactant homeostasis and lipid metabolism. Mutations in the ABCA3 gene have been associated with various pulmonary disorders, including surfactant metabolism disorders and interstitial lung disease, highlighting its importance in respiratory health. The protein is involved in the transportation of phospholipids and cholesterol, which are essential for the synthesis and secretion of pulmonary surfactant, a substance that reduces surface tension in the alveoli and prevents respiratory collapse. Research into ABCA3 has accelerated notably in recent years due to its implications in both inherited and sporadic lung diseases, with various studies focusing on elucidating its molecular mechanisms, structural characteristics, and interactions with other proteins. Advanced techniques such as gene editing, protein expression systems, and structural biology methods are being employed to create recombinant ABCA3 protein, allowing researchers to investigate its function and the impact of specific mutations. Understanding the detailed workings of ABCA3 not only sheds light on its essential role in lung biology but also opens up potential therapeutic avenues for directly targeting ABCA3-related disorders through pharmacological interventions or gene therapy strategies.